Search Results - "Forero, Giovanna"

Safety and efficacy of atogepant for the preventive treatment of episodic migraine in adults for whom conventional oral preventive treatments have failed (ELEVATE): a randomised, placebo-controlled, phase 3b trial by Tassorelli, Cristina, Nagy, Krisztián, Pozo-Rosich, Patricia, Lanteri-Minet, Michel, Sacco, Sara, Nežádal, Tomáš, Guo, Hua, De Abreu Ferreira, Rosa, Forero, Giovanna, Trugman, Joel M

“…Atogepant, an oral calcitonin gene-related peptide receptor antagonist, has been approved for the preventive treatment of migraine, but its efficacy and safety…”
Get full text

Efficacy and Safety of Vilazodone in Patients With Generalized Anxiety Disorder: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Trial by Durgam, Suresh, Gommoll, Carl, Forero, Giovanna, Nunez, Rene, Tang, Xiongwen, Mathews, Maju, Sheehan, David V

“…To evaluate the efficacy, safety, and tolerability of vilazodone as an acute treatment for generalized anxiety disorder (GAD). Vilazodone is a selective…”
Get full text

A DOUBLE‐BLIND, RANDOMIZED, PLACEBO‐CONTROLLED, FIXED‐DOSE PHASE III STUDY OF VILAZODONE IN PATIENTS WITH GENERALIZED ANXIETY DISORDER by Gommoll, Carl, Durgam, Suresh, Mathews, Maju, Forero, Giovanna, Nunez, Rene, Tang, Xiongwen, Thase, Michael E.

“…Background Vilazodone, a selective serotonin reuptake inhibitor and 5‐HT1A receptor partial agonist, is approved for treating major depressive disorder in…”
Get full text

Vilazodone in patients with generalized anxiety disorder: a double-blind, randomized, placebo-controlled, flexible-dose study by Gommoll, Carl, Forero, Giovanna, Mathews, Maju, Nunez, Rene, Tang, Xiongwen, Durgam, Suresh, Sambunaris, Angelo

“…Vilazodone is a selective serotonin reuptake inhibitor and a 5-HT1A receptor partial agonist that is approved for treatment of major depressive disorder in…”
Get full text

Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study by Mago, Rajnish, Forero, Giovanna, Greenberg, William M., Gommoll, Carl, Chen, Changzheng

“…Background Levomilnacipran (1 S , 2 R -milnacipran) is a potent and selective serotonin (5-HT) and norepinephrine (noradrenaline) reuptake inhibitor approved…”
Get full text

A Randomized, Double-blind, Placebo-controlled Trial of the Efficacy and Safety of Levomilnacipran ER 40-120mg/day for Prevention of Relapse in Patients with Major Depressive Disorder by Shiovitz, Thomas, Greenberg, William M, Chen, Changzheng, Forero, Giovanna, Gommoll, Carl P

“…Major depressive disorder is often chronic, with relapse and recurrence common. Levomilnacipran extended-release is a potent and selective serotonin and…”
Get full text

Erratum to: Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study by Mago, Rajnish, Forero, Giovanna, Greenberg, William M., Gommoll, Carl, Chen, Changzheng

Get full text

A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, FIXED-DOSE PHASE III STUDY OF VILAZODONE IN PATIENTS WITH GENERALIZED ANXIETY DISORDER by Gommoll, Carl, Durgam, Suresh, Mathews, Maju, Forero, Giovanna, Nunez, Rene, Tang, Xiongwen, Thase, Michael E.

Get full text